Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase
One of the hallmarks of type 1 but also type 2 diabetes is pancreatic islet inflammation, associated with altered pancreatic islet function and structure, if unresolved. IL-1β is a proinflammatory cytokine which detrimentally affects β-cell function. In the course of diabetes, complement components, including the central complement protein C3, are deregulated. Previously, we reported high C3 expression in human pancreatic islets, with upregulation after IL-1β treatment. In the current investigation, using primary human and rodent material and CRISPR/Cas9 gene-edited β-cells deficient in C3, or producing only cytosolic C3 from a noncanonical in-frame start codon, we report a protective effect of C3 against IL-1β-induced β-cell death, that is attributed to the cytosolic fraction of C3. Further investigation revealed that intracellular C3 alleviates IL-1β-induced β-cell death, by interaction with and inhibition of Fyn-related kinase (FRK), which is involved in the response of β-cells to cytokines. Furthermore, these data were supported by increased β-cell death in vivo in a β-cell-specific C3 knockout mouse. Our data indicate that a functional, cytoprotective association exists between FRK and cytosolic C3.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:121 |
---|---|
Enthalten in: |
Proceedings of the National Academy of Sciences of the United States of America - 121(2024), 8 vom: 20. Feb., Seite e2312621121 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kulak, Klaudia [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 14.02.2024 Date Revised 28.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1073/pnas.2312621121 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368363228 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368363228 | ||
003 | DE-627 | ||
005 | 20240229170948.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240213s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1073/pnas.2312621121 |2 doi | |
028 | 5 | 2 | |a pubmed24n1310.xml |
035 | |a (DE-627)NLM368363228 | ||
035 | |a (NLM)38346191 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kulak, Klaudia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.02.2024 | ||
500 | |a Date Revised 28.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a One of the hallmarks of type 1 but also type 2 diabetes is pancreatic islet inflammation, associated with altered pancreatic islet function and structure, if unresolved. IL-1β is a proinflammatory cytokine which detrimentally affects β-cell function. In the course of diabetes, complement components, including the central complement protein C3, are deregulated. Previously, we reported high C3 expression in human pancreatic islets, with upregulation after IL-1β treatment. In the current investigation, using primary human and rodent material and CRISPR/Cas9 gene-edited β-cells deficient in C3, or producing only cytosolic C3 from a noncanonical in-frame start codon, we report a protective effect of C3 against IL-1β-induced β-cell death, that is attributed to the cytosolic fraction of C3. Further investigation revealed that intracellular C3 alleviates IL-1β-induced β-cell death, by interaction with and inhibition of Fyn-related kinase (FRK), which is involved in the response of β-cells to cytokines. Furthermore, these data were supported by increased β-cell death in vivo in a β-cell-specific C3 knockout mouse. Our data indicate that a functional, cytoprotective association exists between FRK and cytosolic C3 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a C3 | |
650 | 4 | |a FRK | |
650 | 4 | |a IL-1β | |
650 | 4 | |a diabetes | |
650 | 4 | |a β-cell | |
650 | 7 | |a Cytokines |2 NLM | |
700 | 1 | |a Kuska, Katarzyna |e verfasserin |4 aut | |
700 | 1 | |a Colineau, Lucie |e verfasserin |4 aut | |
700 | 1 | |a Mckay, Marina |e verfasserin |4 aut | |
700 | 1 | |a Maziarz, Karolina |e verfasserin |4 aut | |
700 | 1 | |a Slaby, Julia |e verfasserin |4 aut | |
700 | 1 | |a Blom, Anna M |e verfasserin |4 aut | |
700 | 1 | |a King, Ben C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Proceedings of the National Academy of Sciences of the United States of America |d 1915 |g 121(2024), 8 vom: 20. Feb., Seite e2312621121 |w (DE-627)NLM000008982 |x 1091-6490 |7 nnns |
773 | 1 | 8 | |g volume:121 |g year:2024 |g number:8 |g day:20 |g month:02 |g pages:e2312621121 |
856 | 4 | 0 | |u http://dx.doi.org/10.1073/pnas.2312621121 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 121 |j 2024 |e 8 |b 20 |c 02 |h e2312621121 |